Amgen (Nasdaq: AMGN) recently announced it will invest $650 million to expand its biologics manufacturing facility in Juncos, Puerto Rico, a move expected to create nearly 750 jobs across construction and advanced manufacturing. The expansion will increase drug production capacity and integrate advanced technologies into operations, part of the company’s strategy to bolster its U.S.… The post Amgen to invest $650M in Puerto Rico biologics facility appeared first on Pharmaceutical Processi...
